tetradecanoylphorbol acetate has been researched along with Preleukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meo, P; Olashaw, N; Rovera, G | 1 |
| Chorvath, B; Duraj, J; Koppel, J; Kovacikova, M; Sedlak, J; Sobel, A | 1 |
| Apte, RN; Ofir, R; Weinstein, Y | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and Preleukemia
| Article | Year |
|---|---|
Terminal differentiation in human promyelocytic leukaemic cells in the absence of DNA synthesis.
Topics: Cell Differentiation; Cells, Cultured; DNA; Humans; Interphase; Leukemia, Myeloid; Phagocytosis; Phorbols; Preleukemia; Tetradecanoylphorbol Acetate | 1980 |
The protein kinase C inhibitor H7 blocks phosphorylation of stathmin during TPA-induced growth inhibition of human pre-B leukemia REH6 cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Burkitt Lymphoma; Calmodulin; Cell Cycle; Cell Division; Humans; Imidazoles; Isoquinolines; Microtubule Proteins; Phosphoproteins; Phosphorylation; Piperazines; Preleukemia; Protein Kinase C; Stathmin; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1995 |
Alterations in lymphokine secretion during leukemogenesis.
Topics: Animals; Colony-Stimulating Factors; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Interleukin-1; Interleukin-2; Interleukin-3; Leukemia, Experimental; Lymphokines; Macrophages; Mice; Mice, Inbred BALB C; Preleukemia; Tetradecanoylphorbol Acetate | 1988 |